Overview
Monica Hulbert is a Hematologist and an Oncologist practicing medicine in Boston, Massachusetts.
Dr. Hulbert is highly rated in 7 conditions, according to our data. Her clinical expertise encompasses Sickle Cell Disease, Congenital Hemolytic Anemia, Hemoglobinopathy, Hemolytic Anemia, and Bone Marrow Transplant.
She is actively involved in clinical research, co-authoring 54 peer reviewed articles and participating in 2 clinical trials.
Specialties
Licenses
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- EPO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- POS
- PPO
Locations
300 Longwood Ave, Boston, MA 02115
10 Centennial Dr, Peabody, MA 01960
Additional Areas of Focus
Dr. Hulbert has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
2 Clinical Trials
Dana-Farber Cancer Institute
Rachael Grace is a Hematologist and an Oncologist practicing medicine in Boston, Massachusetts. Dr. Grace is highly rated in 13 conditions, according to our data. Her clinical expertise encompasses Pyruvate Kinase Deficiency, Immune Thrombocytopenic Purpura (ITP), Hemolytic Anemia, Splenectomy, and Gallbladder Removal.
Dana-Farber Cancer Institute
Steven Dubois is a Hematologist and an Oncologist practicing medicine in Boston, Massachusetts. Dr. Dubois is highly rated in 11 conditions, according to our data. His clinical expertise encompasses Ewing Sarcoma, Neuroblastoma, Embryonal Tumor with Multilayered Rosettes, and Osteosarcoma.
Dana-Farber Cancer Institute
Matthew Heeney is a Hematologist and an Oncologist practicing medicine in Boston, Massachusetts. Dr. Heeney is highly rated in 14 conditions, according to our data. His clinical expertise encompasses Sickle Cell Disease, Congenital Hemolytic Anemia, Hemolytic Anemia, Hemoglobinopathy, and Splenectomy.
Frequently Asked Questions about Dr. Monica Hulbert
How do I make an appointment with Dr. Monica Hulbert?
You can book an appointment with Dr. Monica Hulbert by calling their office at 617-355-6000. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Monica Hulbert a top-rated expert for Sickle Cell Disease?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Monica Hulbert is classified as an Elite expert for Sickle Cell Disease, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Monica Hulbert specialize in?
While Dr. Monica Hulbert is a Hematology, they have specific expertise in Sickle Cell Disease, Congenital Hemolytic Anemia, and Hemoglobinopathy. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.
Does Dr. Monica Hulbert participate in research or clinical trials?
Yes. Dr. Monica Hulbert has published 54 articles and abstracts on conditions like Sickle Cell Disease. You can view a list of Dr. Monica Hulbert's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Monica Hulbert accept my insurance?
Dr. Monica Hulbert accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 617-355-6000 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- AnemiaDr. Hulbert isElite. Learn about Anemia.
- Congenital Hemolytic AnemiaDr. Hulbert isElite. Learn about Congenital Hemolytic Anemia.
- HemoglobinopathyDr. Hulbert isElite. Learn about Hemoglobinopathy.
- Hemolytic AnemiaDr. Hulbert isElite. Learn about Hemolytic Anemia.
- Sickle Cell DiseaseDr. Hulbert isElite. Learn about Sickle Cell Disease.
- Distinguished
- Hemoglobin SC DiseaseDr. Hulbert isDistinguished. Learn about Hemoglobin SC Disease.
- Advanced
- Hereditary SpherocytosisDr. Hulbert isAdvanced. Learn about Hereditary Spherocytosis.
- Experienced
- Aase SyndromeDr. Hulbert isExperienced. Learn about Aase Syndrome.
- Acquired AgranulocytosisDr. Hulbert isExperienced. Learn about Acquired Agranulocytosis.
- Bone Marrow TransplantDr. Hulbert isExperienced. Learn about Bone Marrow Transplant.
- Evans SyndromeDr. Hulbert isExperienced. Learn about Evans Syndrome.
- Febrile NeutropeniaDr. Hulbert isExperienced. Learn about Febrile Neutropenia.
- Graft Versus Host Disease (GvHD)Dr. Hulbert isExperienced. Learn about Graft Versus Host Disease (GvHD).